Fisher-Titus(Norwalk Ohio) recognized for stroke care

 

Big fucking whoopee.

 

 But you tell us NOTHING ABOUT RESULTS. They remind us they 'care' about us multiple times but never tell us how many 100% recovered.  You have to ask yourself why they are hiding their incompetency by not disclosing recovery results. ARE THEY THAT FUCKING BAD?

Three measurements will tell me if the stroke hospital is possibly not completely incompetent; DO YOU MEASURE ANYTHING?  I would start cleaning the hospital by firing the board of directors, you can't let incompetency continue for years at a time.

There is no quality here if you don't measure the right things.

1. tPA full recovery? Better than 12%?
2. 30 day deaths? Better than competitors?

3. rehab full recovery? Better than 10%?

 

You'll want to know results so call that hospital president(Whoever that is) RESULTS are; tPA efficacy, 30 day deaths, 100% recovery. Because there is no point in going to that hospital if they are not willing to publish results.

 The latest invalid chest thumping here:

Fisher-Titus(Norwalk Ohio) recognized for stroke care 

Fisher-Titus has received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus Quality Achievement Award.

“Fisher-Titus is proud to implement the American Heart Association’s Get with The Guidelines-Stroke initiative,” said Dr. Brent Burkey, president and CEO of Fisher-Titus, in a news release. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes.

"We are pleased to provide this level of stroke care close to home for our patients.”

-

The award recognizes the hospital’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence, according to the release.

Fisher-Titus earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period, the release said.

These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.

Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions.

Additionally, Fisher-Titus received the Association’s Target: Stroke Elite Plus Honor Roll. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke, the release said.

Fisher-Titus also received the Target: Type 2 Honor Roll award from the Association.

To earn this recognition, hospitals must meet quality measures developed with more than 90% compliance for 12 consecutive months for the “Overall Diabetes Cardiovascular Initiative Composite Score,” according to the release.

“We are pleased to recognize Fisher-Titus for their commitment to stroke care,” said Dr. Lee H. Schwamm, national chairperson of the Quality Oversight Committee and executive vice chair of neurology, director of Acute Stroke Services, Massachusetts General Hospital in Boston, Mass. “Research has shown that hospitals adhering to clinical measures through the Get with The Guidelines quality improvement initiative can often see fewer re-admissions and lower mortality rates.”